Fadi N. Joudi

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Fadi N. Joudi, Michael A. O’Donnell · Urologic Oncology Seminars and Original Investigations · 2006 · 243 citations

Medicine, Pharmacotherapy, Urology +7

The Impact of Age on the Response of Patients With Superficial Bladder Cancer to Intravesical Immunotherapy

Fadi N. Joudi, Brian J. Smith, Michael A. O’Donnell et al. · The Journal of Urology · 2006 · 154 citations

Medicine, Immunology, Oncology +14

Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk

Henry Rosevear, Paul T. Gellhaus, Andrew J. Lightfoot et al. · British Journal of Urology · 2011 · 100 citations

Medicine, Surgery, Urology +15

THE IMPACT OF PROVIDER VOLUME ON OUTCOMES FROM UROLOGICAL CANCER THERAPY

Fadi N. Joudi, Badrinath R. Konety · The Journal of Urology · 2005 · 94 citations

Medicine, Surgery, Urology +10

Impact of Previous Bacille Calmette-Guérin Failure Pattern on Subsequent Response to Bacille Calmette-Guérin Plus Interferon Intravesical Therapy

Brian L. Gallagher, Fadi N. Joudi, José L. Maymí et al. · Urology · 2008 · 94 citations

Pharmacy, Immunology, Pharmacotherapy +8